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Background. Mouse embryonic stem (ES) cells can be diﬀerentiated in vitro by aggregation and/or retinoic acid (RA) treatment.
The principal diﬀerentiation lineage in vitro is extraembryonic primitive endoderm. Dab2, Laminin, GATA4, GATA5, and GATA6
are expressed in embryonic primitive endoderm and play critical roles in its lineage commitment. Results. We found that in the
absence of GATA4 or GATA5, RA-induced primitive endoderm diﬀerentiation of ES cells was reduced. GATA4 (−/−)E Sc e l l s
express higher level of GATA5, GATA6, and hepatocyte nuclear factor 4 alpha marker of visceral endoderm lineage. GATA5 (−/−)
ES cells express higher level of alpha fetoprotein marker of early liver development. GATA6 (−/−) ES cells express higher level of
GATA5 as well as mesoderm and cardiomyocyte markers which are collagen III alpha-1 and tropomyosin1 alpha. Thus, deletion
of GATA6 precluded endoderm diﬀerentiation but promoted mesoderm lineages. Conclusions. GATA4, GATA5, and GATA6 each
convey a unique gene expression pattern and inﬂuences ES cell diﬀerentiation. We showed that ES cells can be directed to avoid
diﬀerentiating into primitive endoderm and to adopt unique lineages in vitro by modulating GATA factors. The ﬁnding oﬀers a
potential approach to produce desirable cell types from ES cells, useful for regenerative cell therapy.
1.Background
Embryonic stem (ES) cells derived from the inner cell mass
of preimplanting embryos can be maintained in vitro and
expanded in culture [1, 2]. These pluripotent cells can
potentially be diﬀerentiated and give rise to every tissue of
an organism [3, 4]. The implication for tissue engineering
using human ES cells in medical application is tremendous
and exploration to manipulate their diﬀerentiation into a
d e s i r a b l ec e l lt y p ei sb e i n gu n d e r t a k e n[ 4, 5].
ES cells can be induced to diﬀerentiate in vitro either
by treatment with retinoic acid [6–8] and/or by aggregation
[9, 10], and both genetic and extracellular factors inﬂuence
these processes [11–14]. The main route of diﬀerentiation in
vitro is the extraembryonic endoderm lineage, which mimics
the in vivo diﬀerentiation of cells of the inner cell mass
to form the primitive endoderm [8, 10, 11]. The GATA
transcription factors are expressed in the preimplanting
blastocysts and belong to the group of genes that play critical
roles in endoderm development [12–19]. GATA4-deleted ES
cells are unable to diﬀerentiate spontaneously toward the
endoderm lineage upon aggregation, but the cells respond
to retinoic acid to undergo diﬀerentiation [20, 21]. GATA6
is essential for endoderm development and is also required
for in vitro endoderm lineage diﬀerentiation of ES cells
[22, 23]. Transfection/expression of either GATA4 or GATA6
in ES cells is suﬃcient to induce endoderm diﬀerentiation
[24, 25], and such analysis led to the suggestion that GATA4
is required for ES cells to sense an aggregation signal,
and GATA6 is required to respond to retinoic acid for
endoderm diﬀerentiation [25]. In contrast to zebraﬁsh and
Xenopus in which GATA5 is critical for both endoderm and2 Stem Cells International
heart development [26–29], the phenotype of the GATA5
homozygous knockout mice is relatively mild [30]. The
diﬀerentiation of GATA5-deﬁcient ES cells has not been
previously reported.
The primitive endoderm cells are the ﬁrst epithelial cell
type of the embryo that express laminin and collagen IV and
produce a basement membrane [31, 32]. Thus, induction
of laminin and collagen IV is an indication of endoderm
diﬀerentiation of ES cells [25]. Oct-3/4 (also known as POU
5F1) is a transcription factor associated with pluripotency of
embryonic stem cells, and its expression is lost upon ES cell
diﬀerentiation [33]. Accompanying ES cell diﬀerentiation is
the induction of GATA factor expression, which is indicative
ofEScellprimitiveendodermdiﬀerentiation[25].Oneofthe
GATA-regulated genes, disabled-2 (Dab2), is an informative
marker for the diﬀerentiation of ES cells towards the
endodermlineage[34].Inperiimplantationmouseembryos,
Dab2 is exclusively expressed in extraembryonic endoderm,
and its expression is not found in the embryo proper until
after E8.5 [35]. Moreover, Dab2 is essential for the develop-
ment of extraembryonic endoderm: Dab2 knockout in mice
is early embryonic lethal due to the disorganization of the
endoderm cells [35]. In this study, we investigated the diﬀer-
entiation of pluripotent mouse ES cells that are modiﬁed by
the deletion of either GATA4, GATA5, or GATA6 genes. We
determined whether the deﬁciency of an individual GATA
factor altered the diﬀerentiating lineage of the ES cells and
characterized the gene expression proﬁles of the diﬀeren-
tiated cells by expression microarray analysis. The purpose
of the experiments was to explore approaches to alter the
lineage determination and diﬀerentiation of ES cells in vitro.
2.MaterialsandMethods
2.1. Reagents. All-trans retinoic acid was purchased from
Sigma Aldrich (Milwaukee, WI). Tissue culture ﬂasks (Fal-
con), media, trypsin, and 100X antibiotic-antimycotic solu-
tion (Cellgro, Mediatech, Inc) were purchased from Fisher
Scientiﬁc Inc (Springﬁeld, NJ). Trizol and Lipofectamine
2000 were purchased from Invitrogen (Carlsbad, CA).
Leukemia Inhibitory Factor (LIF) was purchased from
Chemicon (Temecula, CA). ES cell medium and serum
were prepared by Fox Chase Cancer Center Tissue Culture
Facility. For immunodetection, Super Signal West Dura
Extended Duration Substrate (PIERCE, Rockford, IL) was
used. Primary antibodies including rabbit anti-GATA4, goat
anti-GATA5, goat anti-GATA6, and mouse anti-Oct-3/4
were purchased from Santa Cruz Biotechnology, Inc. (Santa
Cruz, CA). Anti-Vimentin and anti-actin antibodies are
purchased from Sigma Aldrich (Milwaukee, WI). Custom
rabbit anti GATA-6 was also used for western blotting and
immunoﬂuorescence experiments. Alexa Fluor 488 and 596
conjugated secondary antibodies and DAPI nuclear counter
staining dye were purchased from Invitrogen/Molecular
Probes (Eugene, Oregon).
2.2. Cell Culture. Mouse ES cells were cultured on gelatin-
coated tissue culture plates in ES cell media cont-
aining HEPES (6g/l), 1X antibiotic-antimycotic, β-merca-
ptoethanol (0.14μM), 15% heat inactivated FBS, and LIF
(1,000U/mL). The plates were precoated overnight at 4◦C
with sterile gelatin solution (0.1%) and then washed three
times with PBS prior to use.
RW-4 mouse ES cells and derived homozygous knockout
cells of the GATA4 (−/−)[ 20], GATA5 (−/−), and GATA6
(−/−)[22]genotypesweremaintainedaccordingtostandard
protocol. Prior to experiments, the ES cells were seeded on
gelatin-coated plates or slide chambers in ES cell medium
with LIF and without feeder cells. Cell diﬀerentiation was
induced by treating with 1μM retinoic acid for four days.
Alternatively, the cells were cultured on petri dishes to allow
aggregation and formation of embryoid bodies for 4 days in
ES cell medium in the absence of LIF.
2.3. Immunoﬂuorescence Microscopy. Brieﬂy, ES cells were
seeded on gelatin-coated glass coverslips in 6-well dishes.
Cells were washed twice with PBS at room temperature,
ﬁxed with 4% paraformaldehyde for 15 minutes, and per-
meabilized with 0.5% Triton X-100 for 5 minutes. Then the
cells were washed three times with PBS, blocked with 3%
BSA in PBS containing 0.1% Tween-20 for 30 minutes, and
incubatedfor1hourat37
◦Cwithprimaryantibodiesdiluted
1:200 in 1% BSA in PBS containing 0.1% Tween-20. GATA
factor expression and localization was detected using Alex-
aFluor 488-conjugated (green ﬂuorescence) or AlexaFluor
546-conjugated(redﬂuorescence)secondaryantibodies.The
cells were incubated in DAPI (blue color) solution for 3
minutes at room temperature to stain the nucleus. Cells
were washed three times, then mounted and sealed in
antifade reagent (Invitrogen/Molecular Probes). Stainings
were viewed with 60X objective lens on a Nikon Eclipse TE
300 microscope linked to a Roper Scientiﬁc photometrics
12-bit range camera. Images were acquired using MetaVue
software and merged using Adobe Photoshop software.
2.4. Electrophoretic Mobility Shift Assay (EMSA). To analyze
the binding ability of GATA transcription factors on the
mouse Dab2 promoter, ES cells were diﬀerentiated with
retinoic acid (1μM) for 4 days. Pellets of ES cells were
collected and the cytoplasmic extract and nuclear extract
were prepared according to published protocols [34]. Brieﬂy,
to isolate cytoplasmic extracts, cell pellets were incubated for
10 minutes on ice in 200μLo fB u ﬀer A containing HEPES
(10mM, pH 7.9), MgCl2 (1.5mM), KCl (10mM), DTT
(0.5mM), PMSF (0.2mM), and a protease inhibitor cocktail
(1X). Cell membranes were then ruptured with a pellet
pestle (Fisher Scientiﬁcs) and the lysates were centrifuged at
10,000rpmfor5minutestoseparatethecytoplasmicextracts
from the nuclear pellets. To isolate nuclear extracts, nuclear
pellets were incubated 30 minutes on ice in 50μLo fb u ﬀer
B containing HEPES (20mM, pH 7.9), MgCl2 (1.5mM),
NaCl (420mM), EDTA (0.2mM), DTT (0.5mM), PMSF
(0.5mM), protease inhibitor cocktail (1X), and glycerol
(25%). Nuclear pellets were agitated every 5 minutes. After
30 minutes the lysates were centrifuged at 10,000rpm for
5 minutes. The protein concentration of the supernatants
(nuclear extracts) was determined using the Bio-Rad DC
Protein assay and aliquots of the supernates were stored atStem Cells International 3
−80◦C until use. Oligonucleotide probes were end-labeled
with 32P and T4 polynucleotide kinase, puriﬁed over a
G25 spin column, and quantitated by liquid scintillation
counting. The binding assay was performed as described
previously [42]. The binding reaction contained HEPES-
KOH(15mM,pH7.9),MgCl2 (1.5mM),KCl(40mM),DTT
(0.5mM), and glycerol (10%), 2μg Poly(dI-dC), nuclear
extracts (10μg), and 20,000cpm radiolabeled probe in a
total volume of 20μl. The binding reaction mixture was
incubated on ice for 30 minutes. For super-shift assays,
antibodies to GATA4, GATA5, and GATA6 were added to
the corresponding reaction and incubated on ice for 1 hour.
Aliquots (20μl) of the binding reaction were loaded on 5%
nondenaturingpolyacrylamidegelsandrunat120Vand4◦C
for 3 hours in 0.5 X TBE running buﬀer using a Vertical
Gel Electrophoresis Apparatus (Model V15-17, GibcoBRL)
to separate bound and unbound oligonucleotides. Gels were
dried for 1 hour and exposed to X-ray ﬁlm (Fuji) for 18
hours at −80◦C. We identiﬁed and tested four GATA binding
sites located upstream of the ATG site of the mouse Dab2
gene (−1904, −1926, −3943, −3894bp). The GATA-binding
oligonucleotides from region −1904bp (PI) and −1926bp
(PII) were most potent for GATA complex formation in
nuclear extracts from ES cells treated with retinoic acid or
fromratcardiomyocytes.TheGATA-bindingoligonucleotide
sequences are as follows:
PI, 5 -ACACATTTTGATAATAATCTTT-3 ;
PII, 5 - CAACTATATAGATAAAGACAAAGG-3 .
T h eu n l a b e l l e dP Ip r o b ea n da nS P 1p r o b ew e r eu s e d
at 300-fold excess as speciﬁc and nonspeciﬁc competitors,
respectively [42]. To test the speciﬁcity of the GATA binding
sequence, we also mutated the “GAT” of the consensus
sequence to CGC, to synthesize m1PI
  and m2PI
  for
competition assays. The sequences of these probes are shown
in Figure 6 .
2.5. Reverse Transcription-Real-Time Polymerase Chain Reac-
tion Analysis. Total RNA was extracted from ES cells mock
treated (media + DMSO) or treated with retinoic acid
for 4 days using Trizol reagent according to the manu-
facturer’s protocol. RNA was puriﬁed with Qiagen Rneasy
mini kit to remove contaminants. Potential contaminating
DNA was removed using TURBO DNA-free kit (Ambion).
RNA was quantiﬁed using the Agilent 2100 BioAnalyzer
in combination with an RNA 6000 Nano LabChip. RNA
was reverse-transcribed (RT) using the M-MLV reverse
transcriptase (Ambion) and a mixture of anchored oligo dT
and random decamers. Two diﬀerent amounts of input RNA
(100 and 20ng) were used to monitor the linearity of the RT
reaction and the eﬃciency of PCR. Real-time PCR “Assay-
on-demand” (Applied Biosystems) Taqman assays were run
using an ABI 7900 HT instrument. The information on the
genes analyzed by real-time RT-PCR is listed in Table 2.
2.6. DNA Expression Array. Gene expression proﬁles were
analyzed to compare undiﬀerentiated and retinoic acid
diﬀerentiated ES cells of wildtype and GATA-deﬁcient
genotypes using a mouse 32K oligochip printed by the
Microarray Facility of Fox Chase Cancer Center [43]. Total
RNA was isolated from 60%–80% conﬂuent ES cell cultures
using the guanidinium/isothiocyanate/phenol/chloroform
method. Total RNA was DNase treated using “DNA free”
kit (Ambion, Austin, TX) according to the manufacturer’s
speciﬁcations. Fifteen micrograms of this DNase-treated
RNA were reverse transcribed and amino allyl dUTP was
incorporated in a reaction containing 500ng oligo (dT)
primers, 1x ﬁrst strand buﬀer (Invitrogen, Carlsbad, CA),
0.01M DTT, 500μM each of dATP, dCTP, dGTP, and
dTTP/aadUTP (2:3 ratio), 40 Units of rRNasin (Promega,
Madison, WI), and 200 Units of SuperScript II reverse tran-
scriptase (Invitrogen, Carlsbad, CA). After brief denatura-
tion and annealing of the primers at 70
◦C for 8 minutes, the
reactionwasincubatedat42
◦Cfor2hours,followedbyalkali
hydrolysis of RNA and cDNA puriﬁcation using Microcon-
30 columns (Millipore, Bedford, MA), and then labeled
with either Cy3- or Cy5-dyes by a coupling reaction using
FluoroLinkTMmonofunctionaldyes(AmershamPharmacia
Biotech, Piscataway, NJ) according to the manufacturer’s
speciﬁcations. Probes were then puriﬁed using StrataPrep
PCR Puriﬁcation Kit (Stratagene, La Jolla, CA). Pairs of
the samples (one labeled with Cy3 and one with Cy5) were
combined, denatured, and preannealed in the presence of
10μg of Cot-1 DNA (Invitrogen, Carlsbad, CA) and 10μg
of poly-dA DNA. Hybridization and washes were performed
as previously described [43]. The procedure was repeated
for each sample, except that the dyes used to label the
RNAs were reversed. Furthermore, for each time point the
hybridizations were repeated using an independent source
of RNA. Intensity extraction and spot quality characteristics
were performed as previously described [43].
The microarray data was then analyzed using GeneSight
3 software (BioDiscovery, Inc., Marina Del Rey, CA). The
data was (i) corrected for background by subtraction of the
local group median, (ii) normalized using a piecewise linear
normalization with 5 bins, typically greater than 1000data
points per bin, and (iii) limited to a minimum expression
level equal to an estimate of the minimum background.
The data was then converted to log2 values, and the mean
and standard deviation determined for each intensity ratio
by combining “dye-ﬂip” replicates. At least two “dye-ﬂip”
experiments were performed for each sample. The mean and
the coeﬃcient of variance were calculated for these values
and used for statistical analysis and clustering. Diﬀerential
expression of individual genes was determined by conﬁdence
analysis[44]andmaximumlikelihoodanalysis[45]toobtain
a ﬁnal list of candidates at a >99% conﬁdence level. The data
was also analyzed using hierarchical clustering [46]w i t ha
Euclidean distance metric.
3. Results
3.1. Endoderm Lineage Diﬀerentiation of Wildtype and GATA
Deﬁcient Embryonic Stem Cells Induced by Aggregation and/or
Retinoic Acid. We ﬁrst compared general markers for endo-
derm diﬀerentiation of wildtype and GATA deﬁcient ES
cells following retinoic acid treatment and/or aggregation,
by Western blot (Figures 1(a) and 1(b)) and Northern4 Stem Cells International
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Figure 1: Endoderm lineage diﬀerentiation of ES cells in vitro. Approximately 1 × 106 ES cells of wildtype or deﬁcient in one of GATA
factor were seeded on 100mm plates as a monolayer culture (m) or cultured in suspension to allow cell aggregation to form spheroids (s).
The cells were also treated with 1μM retinoic acid (RA) or DMSO control. Following a 4-day culture period, cell lysates from monolayer
(a) or from spheroids (b) were prepared for Western blotting analysis. (c) mRNA was prepared for Northern blot analysis. (d) Preservation
of Oct-3/4 protein in embryoid bodies: embryonic stem cells were cultured in medium lacking LIF in suspension to allow the formation
of cell aggregates. The embryoid bodies from a 4-day suspension culture were ﬁxed in formalin, embedded in paraﬃn, sectioned, and
immunostained for Oct-3/4 protein. Representative stainings of two embryoid bodies are shown (left panel, 40×, and right panel, 200×).
blot (Figure 1(c)) analyses. Induction of Dab2, collagen IV,
and laminin was used as markers for commitment to the
extraembryonic endoderm lineage. As shown by Western
blot analysis (Figures 1(a) and 1(b)), wildtype ES cells
diﬀerentiated into endoderm cells after either retinoic acid
treatment or aggregation, as indicated by the expression of
Dab2. GATA4 deﬁcient ES cells, however, did not respond
to cell aggregation; little Dab2 was induced (Figure 1(b)),Stem Cells International 5
but did undergo endoderm diﬀerentiation when treated
with retinoic acid in either monolayer or cell aggregates
(Figures 1(a) and 1(b)), consistent with previous reports
[25]. Notably, GATA4 (−/−) ES cells showed a quantitatively
reduced endoderm diﬀerentiation compared to wildtype
cells in response to either retinoic acid or aggregation.
GATA5-deﬁcient ES cells in monolayer culture exhibited
a reduced response to retinoic acid for Dab2 induc-
tion/endoderm diﬀerentiation. Nevertheless, aggregation
with or without the presence of retinoic acid induced endo-
derm diﬀerentiation (Figure 1(b)). Neither Dab2 nor GATA4
wasinducedbyaggregationand/orretinoicacidtreatmentin
the GATA6 (−/−) cells. Thus, GATA6 is critically required
for endoderm diﬀerentiation of ES cells induced either by
retinoic acid treatment and/or aggregation, consistent with
previous studies [22, 23, 25]. In the absence of GATA6,
GATA5 is induced by retinoic acid (Figure 1(a)) but is insuf-
ﬁcient to induce primitive endoderm lineage diﬀerentiation.
The reduction of Oct-3/4 was used as an indicator of
the loss of pluripotency and diﬀerentiation of ES cells. Oct-
3/4 protein levels were reduced similarly in wildtype and all
GATA-deﬁcient (including GATA6-deﬁcient) ES cells upon
retinoic acid treatment, indicating that retinoic acid induced
the diﬀerentiation of ES cells irrespective of any GATA fac-
tors.Thus,retinoicacidinducesthediﬀerentiationofGATA6
(−/−) ES cells to a lineage other than primitive endoderm.
Without retinoic acid treatment, the Oct-3/4 level was not
reduced upon cell aggregation-induced diﬀerentiation in
wildtypeorGATA-deﬁcientEScells(Figure 1(b)),suggesting
that the formation of embryoid bodies can preserve pluripo-
tencyinasubsetofEScells.Immunostainingshowedthatthe
Oct-3/4-positive cells locate in the interior of the embryoid
bodies (Figure 1(d), an example of a Oct-3/4-positive cell is
indicated by an arrow). Both GATA5 and GATA6 proteins
were diﬃcult to detect by Western blot in cell aggregates
(not shown), likely because of the smaller number of the
cells undergoing primitive endoderm diﬀerentiation. The
expressions of laminin and collagen IV are also diﬃcult
to measure by western blotting because they are secreted
proteins.Thus,weusedpotentiallymoresensitiveassayssuch
as Northern blot (Figure 1(c)) to measure gene expression
in spheroids. Northern blotting is also able to measure the
expression of the secreted proteins laminin and collagen IV,
whichformthebasementmembraneinspheroids.Curiously,
Dab2 mRNA was induced in the aggregated GATA5 (−/−)
ES cells, but GATA4, laminin, and collagen IV were not
signiﬁcantly induced (Figure 1(c)). Following retinoic acid
treatment, GATA5 (−/−) ES cells exhibited an exaggerated
response to retinoic acid and induced the mRNA of Dab2,
GATA4, and GATA6 (Figure 1(c)). The northern blot results
show a disparity between mRNA (Figure 1(c))a n dp r o t e i n
(Figure 1(b))levelsofDab2andGATA4inthesecells.Protein
and mRNA were measured from the same preparation of
cells to show reproducibility, and these results were obtained
repeatedly in three experiments. A likely interpretation of
these data is that GATA5 may have a potential role in
regulating the translation of these mRNAs into proteins.
Either a variation in gene expression level in the wildtype
and GATA-deﬁcient cells or a diﬀerence in the percentage
of cells that undergo diﬀerentiation may account for the
observed diﬀerences in the expression of endoderm markers
determined by Western and Northern blot analysis. This
question was addressed by immunoﬂuorescence microscopy
to detect the expression of GATA4 and Dab2 in individual
cells (Figure 2(a)). When wildtype ES cells were exposed
to retinoic acid, more than 95% of the cells diﬀerenti-
ated into the GATA4 and Dab2 positive extraembryonic
primitive endoderm cells. However, retinoic acid-induced
extraembryonic endoderm diﬀerentiation was reduced in ES
cells that lacked any GATA factor. The percentages of cells
that diﬀerentiated into primitive endoderm lineage (Dab2-
positive) were GATA-4 (−/−), 27%; GATA-5 (−/−), 38%,
and GATA-6 (−/−), <1% (Figure 2(b)). The percentages of
Dab2 and GATA4 positive cells for WT, GATA-4 (−/−),
GATA-5 (−/−), and GATA-6 (−/−) were determined by
counting 100 cells in 5 microscopy ﬁelds and the averages
are presented in histogram (Figure 2(b)). In WT ES cells
the majority of cells expressing GATA4 express also Dab2.
Since expression of Dab2 is required for extraembryonic
endoderm development [35], the absence of Dab2 is a likely
indicator of the lack of endoderm diﬀerentiation. In GATA-
4( −/−) ES cells the expression of Dab2 is conﬁned to a
subset of cells and correlates with the expression of GATA6
(Figure 2(c)). GATA6 (−/−) ES cells are negative for Dab2
butexpressvimentinwhichisstemcellmarkerformesoderm
diﬀerentiation (Figure 2(d)). Thus, the main diﬀerentiation
route following retinoic acid treatment of wildtype ES cells is
the extraembryonic endoderm lineage. However, the absence
of a GATA factor reduces extraembryonic endoderm diﬀer-
entiationandpromotestheEScellstoadoptalternativefates.
3.2.RequirementofGATA5inAggregation-InducedExpression
and Formation of Basement Membrane in Embryoid Bodies.
One peculiar observation is that embryoid bodies derived
from GATA5 (−/−) ES cells were Dab2 positive but lacked
the expression of laminin and collagen IV (Figure 1(c)). We
examined the morphology and the presence or absence of a
basement membrane in the embryoid bodies formed by PAS
staining, which detects the glycoproteins of the basement
membrane [36, 37]. Embryoid bodies derived from GATA5
(−/−) cells exhibited an endoderm outer layer that consisted
of vacuous (visceral endoderm) cells. PAS staining was
negative in GATA5 (−/−) embryoid bodies, indicating the
absence of a basement membrane, while embryoid bodies
formedfromwildtypeEScellsshowedadistinctivebasement
membrane underneath a layer of parietal endoderm-like
cells (Figure 3, arrow). However, basement membranes were
present in both wildtype and GATA5 (−/−)e m b r y o i d
bodies when treated with retinoic acid. Thus, GATA5 is
required for aggregation-induced expression of laminin and
collagen IV and the formation of a basement membrane.
Additionally, basement membrane formation is not essential
for the formation of the visceral endoderm epithelium in
embryoid bodies [38, 39]. This data suggests that GATA5
may be required for aggregation-induced diﬀerentiation of
ES cells into parietal endoderm cells, which are active in
the production of basement membranes and formation of
Reichert’s membrane [40]. Consistent with this possibility,6 Stem Cells International
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Figure 2: Retinoic acid-induced endoderm diﬀerentiation of GATA-deﬁcient ES cells in vitro: ES cells of wildtype, GATA4 (−/−), GATA5
(−/−), or GATA6 (−/−) genotypes in monolayers were treated with or without retinoic acid (1μM) for 4 days. Cells expressing Dab2 and
GATA4 were detected following indirect immunoﬂuorescence staining and counting under ﬂuorescence microscopy. (a) Dab2 (red) and
GATA4 (green) were detected under ﬂuorescence microscopy with DAPI (blue) used for nuclear counterstaining. The percentage of Dab2
and GATA4 positive cells was determined by counting an average of 5 ﬁelds of cells. (b) The percentages of ES cells expressing GATA4 and
Dab2 are presented in histogram. (c) In GATA4 (−/−) the expression of Dab2 correlates with the expression of GATA6. (d) Western blotting
showing the absence of endoderm marker Dab2 and expression of mesoderm marker vimentin in GATA6 (−/−)E Sc e l l s .Stem Cells International 7
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Figure 3: Primitive endoderm diﬀerentiation and the absence of the basement membrane in GATA5-deﬁcient embryoid bodies. Wildtype
and GATA5 (−/−) ES cells were cultured in medium lacking LIF in suspension to allow the formation of cell aggregates on Petri dishes,
with or without retinoic acid (1μM) for 4 days. The embryoid bodies from a 4-day suspension culture were ﬁxed, embedded in paraﬃn,
sectioned, and subjected to PAS staining to detect the basement membrane. Representative stainings are shown (200×). Spheroids of GATA4
(−/−)a n dG A T A 6( −/−) ES cells were previously published [25] and showed that endoderm formation is impaired in GATA4 (−/−)E Sc e l l
spheroids without RA. Endoderm formation in GATA4 (−/−) ES cell spheroids can be restored by treatment with RA for 4 days. Spheroid
of GATA6 (−/−) ES cells lacked endoderm formation that cannot be restored with RA treatment [25].
the wildtype ES cells form spheroids covered with surface
epithelial cells that resemble parietal endoderm (ﬂat cells),
and GATA5 (−/−) ES cells form spheroids covered with
epithelial cells that resemble vacuous visceral endoderm cells
(Figure 3).
3.3. Binding of GATA Factors to the Dab2 Promoter. We
next investigated the promoter binding activity of GATA
factors in nuclear extracts of wildtype and GATA-deﬁcient
ES cells [41]. We identiﬁed and tested four GATA binding
sites located upstream of the ATG site of the mouse Dab2
gene (−1904, −1926, −3943, −3894bp). The GATA-binding
oligonucleotides from region −1904bp (PI) and −1926bp
(PII) were most potent for GATA complex formation in
n u c l e a re x t r a c t sf r o mE Sc e l l st r e a t e dw i t hR Ao rf r o m
rat cardiomyocytes. We used a predicted GATA-binding site
from the mouse Dab2 promoter (referred to as Dab2-PI
site, at −1904bp) to perform electrophoretic mobility shift
assays (EMSA) using nuclear extracts from retinoic acid-
treated cells [42]. As shown in Figure 4(a), wildtype ES
cells possessed the highest GATA binding activity. Most
of the oligo-binding complexes (arrowhead) were super-
shifted by antibodies to GATA4 (doublearrowhead) but
not by antibodies to GATA5 or GATA6 (Figure 4(a)). In
GATA4 (−/−) cells, a complex (arrow, Figure 4(a))w a s
seen that could be eliminated by antibodies to GATA6,
but not by antibodies to GATA4 or GATA5. Comparing to
wildtype ES cells, the loss of any GATA factor greatly reduced
binding activity to the GATA site on Dab2 promoter probes,
suggesting that optimal binding requires the presence of all
the three GATA factors. In GATA5 (−/−) cells the number
of cells expressing GATA4 and Dab2 was low; thus, only
a weak GATA-4-containing complex was shifted by anti-
GATA4 antibodies (Figure 4(a)). GATA6 (−/−)E Sc e l l sd o
not express GATA4 or Dab2 and no GATA binding activity
to Dab2 promoter was observed; but transfection of GATA4
in GATA6 (−/−) ES cells induces Dab2 (red) and GATA4
(green) expression as observed by ﬂuorescence microscopy,
and DAPI (blue) was used for nuclear counter staining
(Figure 4(b)). This data suggests that GATA4 is required for
optimal expression of Dab2 and diﬀerentiation of ES cells
into primitive endoderm. All the binding activities observed
seem to be speciﬁc to the probe, since the inclusion of
unlabeled speciﬁc probe PI in excess of 300-fold inhibited
the binding of GATA factors to radiolabel PI probe of
Dab2 promoter (Figure 4(c)). Also, the binding is speciﬁc
to the GATA binding sites since introduction of mutations
in either forward (m1PI) or reverse (m2PI) GATA binding
site in the sequence abolished the ability of the unlabeled
probe to compete with labeled PI (Figure 4(c)). EMSA was
also performed with another predicted GATA-binding site
from the Dab2 promoter (referred to as Dab2-PII site, at
−1926bp). Similar results were obtained from Dab2-PII
probe as those using the Dab2-PI probe, suggesting that
the GATA-binding properties of ES cells are similar to both
GATA-binding sites (data not shown).8 Stem Cells International
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Figure 4: GATA-binding activity in retinoic acid-induced endoderm diﬀerentiation of wildtype and GATA-deﬁcient ES cells. Wild type
ES cells and those homozygous deﬁcient in GATA4, GATA5, or GATA6 were treated with retinoic acid (1μM) for 4 days. Nuclear extracts
of the ES cells were used for EMSA and supershifted with antibodies speciﬁc for each GATA factor. (a) For EMSA, the labeled Dab2-PI
GATA binding probes were incubated with nuclear extracts from ES cells treated with retinoic acid (1μM) for 4 days. GATA6 (arrow)
and GATA4 (arrowhead) containing complexes are indicated. The supershifted GATA4-containing complexes are indicated by a double-
arrowhead. (b) GATA6 (−/−) ES cells in monolayers were transfected with GATA4 and immunoﬂuorescence stainings of Dab2 (red) and
GATA4(green)wereobservedbyﬂuorescencemicroscopy.DAPI(blue)wasusedfornuclearcounterstaining.(c)ThebindingtothePIprobe
is compared between nuclear extracts from retinoic acid-treated ES cells and cardiomyocytes. GATA4-containing (arrowhead), anti-GATA4
supershifted (double arrowhead), and GATA6-containing (arrow) complexes are indicated. Self competition (SP) assay was performed with
nonradioactive PI probe and nonspeciﬁc competitions were performed with m1pI: PI probe with mutation in GATA binding site 1 (lane 6);
with m2pI: PI probe with mutation in GATA binding site 2 (lane 7), and m1pI/m2 m2pI: probe PI with mutations in both GATA binding
sites (lane 8). αG4 and αG6: antibodies against GATA4 and GATA6; SP: self competition with cold PI; NSP: nonspeciﬁc competition.
T h eE M S Ap a t t e r n sf r o mE Sc e l l sw e r ea l s oc o m p a r e d
to binding activity from rat cardiomyocytes using the same
probe (Figure 4(d)). Nuclear extracts from either ES cells
or cardiomyocytes contain GATA4-containing complexes
(arrowhead) that can be supershifted with antibodies to
GATA4 (double arrowhead), and cardiomyocytes contain
more of a GATA4-negative complex (arrow). Thus, GATA
bindingactivitiesdiﬀeronlysubtlybetweentheretinoicacid-
diﬀerentiated ES cells and cardiac myocytes, suggesting that
there are some diﬀerences in the presence of cofactors in the
two diﬀerent cell types.
3.4. Comparison of Gene Expression Proﬁles in Endoderm
Diﬀerentiation of Wildtype and GATA Deﬁcient ES Cells in
Monolayer Culture. To further characterize the inﬂuence of
the deﬁciency of each GATA factor on the diﬀerentiation
of ES cells, we applied a cDNA microarray analysis [43]t o
compare gene expression proﬁles of wildtype, GATA4 (−/−),
GATA5 (−/−), and GATA6 (−/−) ES cells following retinoic
acid-induced diﬀerentiation of these ES cells cultured as
monolayers. The data has been submitted to the National
Center for Biotechnology Information (NCBI) Gene Expres-
sion Omnibus (GEO) repository (A link will be found atStem Cells International 9
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Figure 5: Expression array analysis and veriﬁcation by quantitative RT-PCR of retinoic acid-induced endoderm diﬀerentiation of GATA-
deﬁcientEScells.WildtypeembryonicstemcellsandthosehomozygousdeﬁcientinGATA4,GATA5,orGATA6wereculturedasmonolayers
and treated with the DMSO carrier as a control or retinoic acid (1μM) for 4 days. (a) Representative morphology of the cells with or without
retinoicacid.(b)ThecellswereanalyzedbycDNAexpressionmicroarraycomparingwithorwithoutretinoicacid.Theresultswereanalyzed
by hierarchical clustering. Individual colored rows represent change inexpression following retinoic acid treatment of a singlegene/sequence
tag. Red rows indicate an increase in expression and green rows indicate a decrease in expression, as shown by the color scale bar. (c)–(h)
Veriﬁcation of expression of a panel of selected genes by quantitative RT-PCR Relative gene expression changes with or without retinoic acid
in monolayer cells (c) and spheroids (d) are presented as “Heat-Maps”. The ﬁgure displays grey scale shades representing the Ct values. Ct
(cycle threshold) is the number of PCR cycles at which the ﬂuorescence reaches a signiﬁcant level above the baseline, given that the higher
the starting copy number of the nucleic acid target, the sooner ﬂuorescence increases. The relative levels of a particular transcript between
samples can be calculated using the equation: relative quantity = 2 − Ct. The ampliﬁcation of TBP shows similar amounts of template in
all samples. (e)–(h) values that represented relative mRNA levels of the monolayer ES cells are shown and compared. The mRNA values of
undiﬀerentiated ES cells are deﬁned as “1” for comparison. The detection of a real-time RT-PCR signal in a speciﬁc GATA transcript in the
ES cells that were homozygous knockout of that GATA gene is likely due to the presence of transcripts from the mutant/inactive GATA locus.
PI probe: ACACATTTTGATAATAATCTTT Forward GATA site
||||||||||||||||||||||
TGTGTAAAACTATTATTAGAAA
m1PI probe:
Backward GATA site
ACACATTTTCGCAATAATCTTT Mutation 1 (m1PI probe)
m2PI probe: TGTGTAAAACTATTATCGCAAA Mutation 2 (m2PI probe)
Figure 6
http://www.ncbi.nlm.nih.gov/projects/geo/query/acc.cgi?acc
=GPL4486, and the link will be activated upon publication
of the manuscript).
Examination of individual genes, such as Dab2, laminin,
collagen, and each GATA factor showed that the changes
are consistent with Western and Northern blotting analysis
(Table 1) with exception of collagen IV which shows some
diﬀerence between the ES cells monolayer cDNA array and
the spheroid northern blot. For most of the other genes the
cDNA array approach veriﬁed the northern blotting and the
western blotting results. The morphology of undiﬀerentiated
wildtype or GATA-deﬁcient ES cells is similar in absence
of retinoic acid. Treatment with retinoic acid, however,
induced unique morphological changes in each cell type
(Figure 5(a)), suggesting that the diﬀerential expression
of GATA factors inﬂuences cell properties including
morphology.
The expression proﬁles of the wildtype and GATA
knockout ES cells induced by retinoic acid were com-
pared by signiﬁcance analysis of microarrays (SAM) andStem Cells International 11
Table 1: Information on genes analyzed by real-time RT-PCR using Taqman assay.
Gene
Symbol NCBI Gene Reference Target
Exons
Context Sequence
Tbp NM 013684,NM 013684 3 ATCCCAAGCGATTTGCTGCAGTCAT
Gata4 NM 008092,AF179424,U85046, M98339,AB075549 3 CGCCGCCTGTCCGCTTCCCGCCGGG
Gata5 NM 008093,U84725 1 AGGACCAGCTTCGTACCTGACTTCT
Gata6 NM 010258,AF179425 5 CTCAGGGGTAGGGGCATCAGTGATG
Dab2 NM 023118,U18869 1 TAGCTAGTCCGTGTACTTTGTGGGT
Pou5f1 NM 013633,X52437,M34381,BC068268 2 GCGTTCTCTTTGGAAAGGTGTTCAG
Afp NM 007423,V00743,BC066206, AK075972,
AK010934,AK076053,AK076197 3 GTGTTTAGAAAGCCAGCTATCTGTG
Mest NM 008590,D16262,AK031718,AK032881,AK034949,BC006639 1 TCGCTTGCGCAGGATGAGAGAGTGG
Lpr2 AF197160,BC040788 11 CTATGCAGAGATGGACACTGAGCAA
Hnf4a NM 008261,D29015,BC039220 8 ATGCTTCTCGGAGGGTCTGCCAGTG
Lrp1 NM 008512,X67469,AF367720 15 CCTGCTTGGCGAACCCATCCTACGT
Lama1 NM 008480,J04064 19 AAACTGCCGAGCCTGTGACTGCCAC
Col3a1 NM 009930,BC058724,M18933,AK029212,
BC052398,AK013329,AK041115,AK048546,BC043089 4 GTGGCCAAAATTATTCTCCCCAATT
Tdgf1 NM 011562,M87321 15 AAGACTGGGGAAACAGAGTGGATTG
Tpm1 NM 024427,X64831,M22479,BC026720,
AK002271,AK003175,AK032942,AK077713 1 CGGAGCAAGCAGCTGGAAGATGAGC
H19 X58196,BC025150 1 GGACTGGAGACTAGGCCAGGTCTCC
Tbp was used as normalization control.
Afp: alpha fetal protein; Col3a1: collagen III alpha 1; H19: fetal liver RNA transcript; Lama 1: laminin alpha 1 gene; Lrp: lipoprotein-related receptor protein;
Mest: mesoderm-speciﬁc transcript; Pou5f1: Oct-3/4; Tdgf1: Teratocarcinoma derived growth factor 1 (cripto); Tbp: TATA box binding protein; Tpm1:
tropomyosin 1, alpha.
hierarchical clustering (Figure 5(b))[ 44–46]. Visual obser-
vation indicates that the eﬀect of GATA4, GATA5, or
GATA6 deﬁciency on retinoic acid-induce changes in gene
expression is profound and the deletion of each GATA
factor shows a drastically altered gene expression proﬁle
(Figure 5(b)). In experiments comparing signals of RNA
from various preparations (2 to 4 preparations for each cell
types) of the same cell type, the expression proﬁles were
similar, indicating that the observed diﬀerences between cell
types were not due to experimental variation but reﬂected
expression diﬀerences associated with the genotypes. Sorting
by mathematical modeling [46] indicates that expression
proﬁles are more similar between wildtype and GATA5
(−/−) ES cells than either GATA4 (−/−) or GATA6 (−/−)E S
cells (Figure 5(b)) .T h u s ,G A T A 4 ,G A T A 5 ,a n dG A T A 6c a n
all dramatically modify gene expression proﬁles of ES cells
following retinoic acid treatment. Although many changes in
geneexpressionareapparentlyassociatedwiththeendoderm
lineage, most of these changes (that occur in GATA4 (−/−)
and GATA5 (−/−) ES cells) are not critical for the function
of the endoderm cells, and only a few critical genes, such
as Dab2, may be required for endoderm formation in
early embryonic development. The cDNA arrays show that
GATA6(−/−)EScellsdiﬀerentiatetowardmesodermlineage
with expression of mesoderm markers (mesoderm tran-
script, collagen III alpha) and cardiac marker (tropomyosin
alpha1).
3.5. Veriﬁcation of a Panel of Markers Identiﬁed from CDNA
Microarray Analysis. We selected a panel of genes identiﬁed
from the expression array experiments with large fold
changes (either upregulated or downregulated) for further
veriﬁcation (Table 2). Several lineage markers with known
importance in ES cell diﬀerentiation, which were also
identiﬁed to have signiﬁcant changes in the expression array,
were included for comparison. The expression of these genes
was analyzed by quantitative real-time PCR, and the result is
presented as “Heat Maps” (Figure 5(c)). In this experiment,
we also investigated the expression pattern of this panel of
genes in embryoid bodies treated with or without retinoic
acid (Figure 5(d)).
By comparing gene expression in monolayer
(Figure 5(c)) and spheroids (Figure 5(d)), aggregation-
induced genes were found to include GATA4, GATA6,
Dab2, Laminin (lama1), Afp, H19, and Lrp2, in wildtype
ES cells in the absence of retinoic acid. Aggregation is
able to reduce expression of Tdgf1 (cripto) and Oct-3/4
(pou5f1) in wildtype ES cells in the absence of retinoic acid.
Expression of GATA5, Col3α1, MEST, and Lrp1 is dependent
on retinoic acid in the wildtype ES cells. Some unique and
subtle diﬀerences in gene expression proﬁles in response to
retinoic acid versus aggregation are observed in wildtype
and GATA-deﬁcient ES cells (Figures 5(c) and 5(d)). For
example, in monolayer culture of GATA6 (−/−) ES cells,
retinoic acid induced higher expression of Col3α1, MEST,
a n dT p m 1t h a ni ns p h e r o i dc u l t u r e .12 Stem Cells International
Table 2: Limited list of genes whose expression is signiﬁcantly altered following retinoic acid treatment of ES cells grow in monolayer
cultures.
WT GATA4 (−/−) GATA5 (−/−) GATA6(−/−)
Dab2 4.38, 3.77 2.00, 1.80 4.09, 3.24 0.05, 0.48
GATA4 3.32 0.22 2.58 0.91
GATA6 2.04, 2.74, 2.51, 2.38 2.15, 2.08 1.94 0.41, 0.01
collagen IVa1 2.58, 2.30 2.86, 2.73 2.94, 2.72 2.72, 3.00, 2.84
collagen IVa2 1.88 2.66 2.48 2.48, 3.03
laminin alpha1 2.52 2.59 3.79 0.20
laminin beta1 2.74, 2.65 2.13 3.05 2.01
laminin gamma1 2.27, 2.00 2.20 2.38, 2.94, 2.02 2.90
keratin gene 8 3.20, 3.005, 2.301 2.59, 2.2, 2.17 2.27, 1.61 3.08, 3.05, 2.68, 1.99
procollagen III 0.87 0.48 1.07 3.96
lrp1 2.55 1.76 2.90, 2.35 0.15, 0.27
lrp2 2.28, 2.15 1.83 2.37 0.09, 0.65
Talin 2.52 2.87 2.93 3.62
fetal liver H19 2.20, 2.65, 2.35 2.65, 2.38 3.86, 3.80, 3.68 3.82, 3.80
igf2 2.29 3.26 2.66 3.75
mesoderm transcript 1.29 1.77 2.09 3.12
tropomyosin 1alpha 1.36, 1.37, 1.32 2.2, 2.17, 2.1, 1.9 1.42, 1.38, 1.35 3.68, 3.64, 2.94
alpha fetoprotein 3.0 3.09 3.61 3.22
POU domain class 5 0.66 0.00 −2.01 −5.18
Arc −2.37 −1.10 −0.79 −1.39
Ran small G protein −2.28 −0.23 −0.40 −1.65
The monolayer cultures of ES cells were treated with or without retinoic acid (RA) for 4 days and mRNA was isolated for expression array analysis. A selected
list of genes of interest with large-fold expression changes following RA treatment is presented. The fold-changes in expression between with or without RA
can be calculated as 2n. The number “n” is listed in the table. Multiple numbers in a category indicate several cDNA entries of the same gene on the cDNA
chip. The presence of hybridization signal for a GATA transcript in cells that were homozygous knockout of the GATA gene is likely due to the presence of
the mutant GATA transcripts that are inactive. The authors will provide the full data of the expression array experiments if requested. The complete list of
diﬀerentially expressed genes will be found online: http://www.ncbi.nlm.nih.gov/projects/geo/, Accession “GPL4486”.
Several points from the analysis of the expression proﬁles
(Figure 5) can be noted. First, there is interregulation
betweenGATAfactorexpression(Figure 5(e)).Retinoicacid-
induced GATA4 expression depends on GATA6 but not on
GATA5; the induction of GATA5 expression by retinoic acid
is enhanced by the deletion of either GATA4 or GATA6;
deletion of either GATA4 or GATA5 does not signiﬁcantly
alter retinoic acid-induced GATA6 expression.
HNF4 was strongly upregulated by retinoic acid in
GATA4 (−/−) ES cells in correlation with the upregulation
of GATA6 (Figure 5(f)).In the absenceof GATA6, mesoderm
lineage seems to be favored, as indicated by the expression of
collagen3alpha1(Figure 5(f)),whichhasbeenreportedtobe
speciﬁcally expressed in embryonic mesoderm, sclerotomes,
dermatomes, and in forming connective tissues [47]. GATA6
is required for endoderm lineage diﬀerentiation, as indicated
by the reduced expression of endoderm markers such as
Dab2, laminin, and Afp in both the absence or presence of
retinoic acid (Figure 5(g)).
Other GATA6-independent (but GATA4-dependent)
genes include fetal liver transcript H19 [48], cardiac marker
tropomyosin 1 alpha (Tpm1), and Mest, the mesoderm
speciﬁc transcript [49, 50]( Figure 5(h)). In general, deletion
of an individual GATA factor seems to promote alternative
lineages of ES cell diﬀerentiation.
4. Discussion
We investigated the in vitro diﬀerentiation of murine ES cells
with a deﬁciency of either GATA4, GATA5, or GATA6 and
compared them to wildtype ES cells. The rationale for the
experiments was that GATA factors are involved in the early
step of cell lineage determination of the pluripotent cells
of the inner cell mass, the in vivo equivalents of ES cells,
and thus alterations of GATA factors might inﬂuence ES cell
lineage determination.
The inability of GATA6 (−/−) ES cells to undergo
extraembryonic endoderm diﬀerentiation is consistent with
the ﬁnding that GATA6 deletion results in defect in endo-
derm development and early embryonic lethality [22, 23].
Although deletion of either GATA4 or GATA5 reduces
but not impairs endoderm lineage diﬀerentiation of ES
cells, the loss of either GATA4 or GATA5 does not
block extraembryonic endoderm development in mouse
early embryos [30, 51]. Nevertheless, the GATA4 null
endoderm is defective in its role in cardiac induction
[19, 52]. Likely, the requirement of GATA4 and GATA5
in extraembryonic induction observed in vitro can be
compensated in vivo, but the GATA factors may con-
tribute to other uncharacterized extraembryonic endoderm
function.Stem Cells International 13
Wildtype ES cells express endoderm markers such as
Dab2, GATA4, GATA6, laminin, and collagen IV following
diﬀerentiation with retinoic acid or aggregation. Expression
ofGATA5isnotobservedinwildtypeEStreatedwithretinoic
a c i db u ti so b s e r v e di nG A T A 4 ( −/−) ES or GATA6(−/−)
ES cells treated with retinoic acid. GATA4 (−/−)E Sc e l l s
express liver markers HNF4 and GATA6 in vitro; indeed,
study reported that GATA6 regulates HNF4 and is required
for diﬀerentiation of visceral endoderm in the mouse
embryo [22].G A T A 6( −/−)E Sc e l l se x p r e s sm e s o d e r ma n d
cardiac markers (mesoderm transcript, collagen 3 alpha1
and tropomyosin 1 alpha), while GATA5 (−/−) cells seem
to have regulatory roles in the expression of endoderm
marker proteins. We observed that in GATA5 (−/−) ES cells,
the mRNA and protein levels of several endoderm markers
including Dab2 and GATA4 are disassociated (Figure 1).
When stimulated by retinoic acid, endoderm markers are
highly induced at the mRNA level in spheroids from GATA5
(−/−) ES cells, to a level much greater than that in wildtype
ES cells. However, judging from the protein level, GATA5
(−/−) ES cells express less of these endoderm markers. Thus,
GATA5 may have a role in the regulation of the translation
of these mRNAs into protein. We also found that the
cell-aggregation-induced expression of basement membrane
components requires GATA5. The ability to produce proper
basement membrane is thought to be important for early
embryogenesis [36–39]. However, GATA5 deﬁciency does
not appear to impact primitive endoderm formation in
mouse embryonic development [30].
WefoundthatGATA5(−/−)EScellsexhibitonlyasubtle
phenotype in the formation of embryoid bodies. Likely,
the function of GATA5 in primitive endoderm develop-
ment is redundant with GATA4 and GATA6. Alternatively,
GATA5 may be needed for aggregation-induced ES cell
diﬀerentiation into parietal endoderm lineage. The parietal
endoderm cells express high levels of basement membrane
components (laminin and collagen IV) and are responsible
for producing basement membrane for the thick Reichert’s
membrane in the early embryos [8, 10]. Several observations
from these experiments may have biological implications
to establish regenerative therapy. Diﬀerentiation of ES cells
could be directed to mesoderm formation by deletion of
GATA6, which may improve the eﬃciency to generate
cardiomyocytes derived from ES cells. Deletion of GATA4
in ES cells could direct to formation of liver cells in
vitro. However, much more work is needed to improve
the use of deletion of either GATA factor for regenerative
therapy.
5. Conclusions
We found that the deletion of one GATA factor, either
GATA4, GATA5, or GATA6, can drastically alter the gene
expression proﬁles and lineage determination of ES cells
induced to diﬀerentiate by retinoic acid. ES cells lacking a
singleGATAfactor,eitherGATA4,GATA5,orGATA6,exhibit
a unique pattern of gene expression proﬁle when diﬀerenti-
ated. Deletion of GATA6 terminates the diﬀerentiation of ES
cells to endoderm but leads to mesoderm lineage diﬀerenti-
ation. Normally, during in vitro diﬀerentiation, the majority
of ES cells diﬀerentiate into primitive endoderm cells [25].
Thus, the deletion of GATA6 allows the selection of lineage
other than yolk sac endoderm. This study demonstrates a
potential approach in redirecting the lineage determination
of ES cells in vitro by altering the expression of GATA
factors.
OtherAssays
Northern blotting, Western blotting, and immunohisto-
chemistry were performed following standard procedures as
described previously [25, 35]. Transfection was performed as
described previously [25].
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